HAMSIAA protects cyclophosphamide induced immunosuppression by modulating gut homeostasis and purine metabolism

Introduction Dietary supplementation with functional starches serves as a promising intervention strategy for immune regulation, yet the immunomodulatory efficacy and underlying mechanisms of newly developed modified starch derivatives remain to be further explored. In this study, a cyclophosphamide (CTX) induced secondary immunodeficiency mouse model was adopted to investigate the immunoregulatory effects of indole…

HAMSIAA protects cyclophosphamide induced immunosuppression by modulating gut homeostasis and purine metabolism.
Asia Food Times editorial cover generated for this article. Source: Frontiers in immunology / Europe PMC. Licence: CC BY.

Introduction Dietary supplementation with functional starches serves as a promising intervention strategy for immune regulation, yet the immunomodulatory efficacy and underlying mechanisms of newly developed modified starch derivatives remain to be further explored. In this study, a cyclophosphamide (CTX) induced secondary immunodeficiency mouse model was adopted to investigate the immunoregulatory effects of indole 3 acetylated high amylose maize starch derivative (HAMSIAA).

What the research examined

Methods Mice were fed a basal diet supplemented with 0.5% or 1% HAMSIAA for nine consecutive days, with CTX administered starting on day 7. Immune organ injury, splenic CD4⁺/CD8⁺ T cell balance, serum immunoglobulins, intestinal barrier integrity, gut microbiota composition and purine related metabolome were assessed. Results HAMSIAA attenuated CTX triggered damage to immune organs, maintained the splenic CD4⁺/CD8⁺ T cell balance, and increased serum levels of Immunoglobulin A (IgA), immunoglobulin G (IgG), and immunoglobulin M (IgM).

What the findings mean

In addition, HAMSIAA improved intestinal barrier integrity and modulated gut microbiota composition, as evidenced by changes in the Bacillota/Bacteroidota (B/B) ratio and a reduction in Pseudomonadota abundance. Metabolomic analyses further revealed that HAMSIAA was associated with modulation of the purine salvage pathway, including downregulation of hypoxanthine guanine phosphoribosyltransferase (HGPRT) and altered levels of metabolites such as inosine and xanthine, which may contribute to its immunoprotective effects. Discussion Collectively, the present findings suggest that HAMSIAA is a promising functional food ingredient for the prophylactic mitigation of chemotherapy induced immunosuppression, and provide support for its translational application in the field of immunonutrition.

Study authors: Zhang D, Song Y, Guo S, Cui X, Dong H, Li Q, Wang Q, Mackay CR, Qu X.. This report is based on the openly licensed abstract and source record and has been formatted for newsroom reading.

Original source

Frontiers in immunology

https://europepmc.org/articles/PMC13581576

This report is prepared from the public source listed above for news and industry-information purposes. Original research, text, trademarks and images remain with their authors and rights holders; open material is used under the licence identified by its source. Rights holders may contact rights@asiafoodtimes.com with evidence of ownership, and verified concerns will be corrected or removed promptly. This article is not investment, legal, medical or nutrition advice.